<DOC>
	<DOCNO>NCT01943942</DOCNO>
	<brief_summary>The objective study confirm two formulation montelukast tablet bioequivalent . Test product Montelukast ( 10 mg tablet ; GlaxoSmithKline ) reference product Singulair ( 10 mg tablet ; Merck Sharp &amp; Dohme ) . The single dosage one tablet . The study prospective , open-label , randomize , crossover , single dose , 02 treatment , 02 sequence 02 period , fast condition . The population compose 32 healthy volunteer , gender , adult 18-50 year . The comparative bioavailability two formulation evaluate base statistical comparison relevant pharmacokinetic parameter , obtain data drug concentration blood .</brief_summary>
	<brief_title>Bioequivalence Study Montelukast 10 mg Tablets</brief_title>
	<detailed_description />
	<mesh_term>Montelukast</mesh_term>
	<criteria>Free participation accord Mexican regulation , Helsinki Declaration , Good Clinical Practice . Healthy , 18 50 year . Body Mass Index 19 27 In good health complete medical history laboratory test . Blood pressure 13090/ 9060 mm Hg ; heart rate 55100 beat per minute , respiratory rate 1420 movement per minute . Laboratory test +/ 10 % normal interval ( blood cytology , blood chemistry 27 element , Hepatitis B C antigens , HIV , urinalysis , antidoping , pregnancy , electrocardiogram ) Alteration vital sign Not comply inclusion criterion History cardiovascular , kidney , hepatic , muscular , metabolic , gastrointestinal ( include constipation ) , neurologic , endocrine , hematopoietic ( kind anemia ) , asthma , mental organic disease . Those suffer muscular trauma 21 day begin study . Requirement kind medication course study , except study medication . History dyspepsia , gastritis , esophagitis , duodenal gastric ulcer . Exposure medication know inducer inhibitor hepatic enzyme administration potentially toxic medication 30 day study begin . Administration medication 14 day 5 halflives ( whatever longer ) previous begin study . Hospitalization cause seven month begin study . Administration investigational drug 60 day study . Allergy antibiotic nonsteroidal antiinflammatory analgesic . Alcohol ingestion intake beverage contain xanthine ( coffee , tea , cocoa , chocolate , mate , cola drink ) ingestion charcoal grill food grapefruit orange juice 72 hour hospitalization tobacco smoke 72 hour begin study . Blood donation loss = &gt; 450 ml 60 day begin study . History drug alcohol abuse . Special diet requirement , instance vegetarian diet . Inability understand nature , aim , possible consequence study . Noncooperative attitude study . Positive antidoping pregnancy test . Breastfeeding . Females contraceptive hormonal treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Mexico</keyword>
	<keyword>Montelukast</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Bioequivalence</keyword>
</DOC>